La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company offers GIAPREZA (angiotensin II), an injection for intravenous infusion indicated to increase blood pressure in adults with septic or other distributive shock. It is also developing LJPC-0118 for the treatment of severe malaria; and LJPC-401 (synthetic human hepcidin), a clinical-stage investigational product to treat conditions characterized by iron overload, including hereditary hemochromatosis, beta thalassemia, sickle cell disease, myelodysplastic syndrome, and polycythemia vera. The company was founded in 1989 and is headquartered in San Diego, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [01/15/2020 10:10 PST] La Jolla Pharmaceutical Company (NASDAQ:LJPC), Up By 100.00% ($7.00) From $7.000 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [01/15/2020 10:10 PST] La Jolla Pharmaceutical Company (NASDAQ:LJPC), Up By 100.00% ($7.00) From $7.000 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [01/15/2020 10:10 PST] La Jolla Pharmaceutical Company (NASDAQ:LJPC), Up By 100.00% ($7.00) From $7.000 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [01/15/2020 10:10 PST] La Jolla Pharmaceutical Company (NASDAQ:LJPC), Up By 100.00% ($6.00) From $6.000 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [01/15/2020 07:54 PST] LJPC, Expected to Trade Higher After Bullish Insider Trading
• [01/15/2020 07:49 PST] LJPC Expected to Trade Up Short Term
• [01/14/2020 11:58 PST] LJPC Expected to Trade Up After Bullish Patterns Develop
• [01/13/2020 10:10 PST] La Jolla Pharmaceutical Company (NASDAQ:LJPC), Up By 100.00% ($5.21) From $5.210 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [01/13/2020 07:54 PST] LJPC Expected to Trade Up After Bullish Patterns Develop
• [01/10/2020 07:40 PST] LJPC Expected to Trade Up After Bullish Patterns Develop
• [01/09/2020 21:17 PST] Market Maker Surveillance Report. LJPC, Winning Stocks With Lowest Price Friction For Thursday, January 9th 2020
• [12/30/2019 07:40 PST] LJPC Expected to Trade Down After Bearish Patterns Develop
• [12/24/2019 10:10 PST] La Jolla Pharmaceutical Company (NASDAQ:LJPC), Up By 100.00% ($3.91) From $3.910 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [12/18/2019 07:47 PST] LJPC Expected to Trade Up After Bullish Patterns Develop
• [12/16/2019 11:07 PST] La Jolla Pharmaceutical Company (NASDAQ:LJPC), Up By 100.00% ($3.24) From $3.240 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [12/16/2019 11:07 PST] La Jolla Pharmaceutical Company (NASDAQ:LJPC), Up By 100.00% ($3.29) From $3.290 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [12/10/2019 07:43 PST] LJPC Expected to Trade Up After Bullish Patterns Develop
• [12/05/2019 07:44 PST] LJPC Expected to Trade Up After Bullish Patterns Develop
• [11/25/2019 21:16 PST] Market Maker Surveillance Report. LJPC, Losing Stocks With Lowest Price Friction For Monday, November 25th 2019